Drug intelligence / Profile preview

isochlorogenic acid C

Development stage
Preclinical
Modality
Small Molecules
Administration
Not Applicable (research Use Only)
01

Overview

Isochlorogenic acid C is a naturally occurring phenolic compound classified as a dicaffeoylquinic acid derivative. It is found in various plants and foods and is produced via the condensation of quinic acid and caffeic acids. Isochlorogenic acid C exhibits multiple bioactivities including antioxidant, anti-inflammatory, antiviral (notably anti-HIV-1 integrase activity), hepatoprotective (anti-HBV), hypolipidemic (lipid-lowering), anti-fibrotic effects, and inhibition of smooth muscle contraction[9][10][6]. Mechanistically, it has been shown to: - Promote reverse cholesterol transport by upregulating LXRα-mediated pathways while downregulating LDLR and CD36 expression in macrophages. - Suppress inflammatory mediators such as iNOS, COX2, IL-1β. - Inhibit Erk/JNK/NF-κB signaling pathways to reduce inflammation-induced synovial proliferation and promote apoptosis in fibroblast-like synoviocytes[7][5]. Preclinical studies suggest potential for treating hyperlipidemia without causing liver steatosis or organ toxicity at tested doses[5]. It is primarily used for research purposes; no approved pharmaceutical formulations are available.

Other names
4,5-dicaffeoylquinic acid3,4-dicaffeoylquinic acid4,5-DCQA
02

Targets

NR1H3 (Liver X receptor beta)ERKJNK (Mitogen-activated protein kinase kinase kinase family)

Beyond the preview

Go deeper on isochlorogenic acid C.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on isochlorogenic acid C.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call